The Prevalence of Malaysian Children Aged ≥ 6 to ≤ 36 Months at Risk of Anaemia - Trial NCT05181436
Access comprehensive clinical trial information for NCT05181436 through Pure Global AI's free database. This phase not specified trial is sponsored by Danone Specialized Nutrition (M) Sdn Bhd and is currently Active, not recruiting. The study focuses on Anemia. Target enrollment is 1215 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Danone Specialized Nutrition (M) Sdn Bhd
Timeline & Enrollment
N/A
Jul 19, 2022
Feb 28, 2023
Primary Outcome
Percentage of Malaysian Children aged ≥ 6 to ≤ 36 months with SpHb (g/dL) 12 g/dL vs ≥12 g/dL measured using Masimo Rad-67.
Summary
The main purpose of this study is to determine the prevalence of Malaysian children aged ≥ 6
 to ≤ 36 months at risk of anaemia by measuring Total Haemoglobin (SpHb) using a non-invasive
 haemoglobin assessment. Eligible subjects, and their parent(s) / legally acceptable
 representative(s) where applicable, who fulfil all the inclusion and none of the exclusion
 criteria will be enrolled into the study. Parameters will be recorded during the subjects
 visit at the MCHC using a self-administered 24-hour Diet Recall. Demographics and subject /
 family characteristics will be recorded at this visit by using questionnaire built into Iron
 Strong app which act as a data collection tool.For subjects with haemoglobin level 12 g/dL,
 the subject will be considered at risk of anaemia and as a standard operating procedure,
 the child will be referred to HCPs for further clinical assessment.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05181436
Non-Device Trial